Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,10alpha,13alpha-kaura-9(11),16-dien-18-oate | - |
Leishmania amazonensis | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,10alpha,13alpha-kaura-9(11),16-dien-18-oate | - |
Leishmania braziliensis | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,10alpha,13alpha-kaura-9(11),16-dien-18-oate | - |
Leishmania major | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,10alpha,13alpha-kaura-9(11),16-dien-18-oate | - |
Leishmania panamensis | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,9beta,10alpha,13alpha-kaur-16-en-18-oate | - |
Leishmania amazonensis | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,9beta,10alpha,13alpha-kaur-16-en-18-oate | - |
Leishmania braziliensis | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,9beta,10alpha,13alpha-kaur-16-en-18-oate | - |
Leishmania major | |
(1R,4S,6R)-4-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-yl 5beta,8alpha,9beta,10alpha,13alpha-kaur-16-en-18-oate | - |
Leishmania panamensis | |
3alpha-cinnamoyloxy-9beta-hydroxy-ent-kaur-16-en-19-oic acid | - |
Leishmania amazonensis | |
3alpha-cinnamoyloxy-9beta-hydroxy-ent-kaur-16-en-19-oic acid | - |
Leishmania braziliensis | |
3alpha-cinnamoyloxy-9beta-hydroxy-ent-kaur-16-en-19-oic acid | - |
Leishmania major | |
3alpha-cinnamoyloxy-9beta-hydroxy-ent-kaur-16-en-19-oic acid | - |
Leishmania panamensis | |
3alpha-cinnamoyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania amazonensis | |
3alpha-cinnamoyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania braziliensis | |
3alpha-cinnamoyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania major | |
3alpha-cinnamoyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania panamensis | |
3alpha-p-coumaroyloxy-9beta-hydroxy-entkaur-16-en-19-oic acid | - |
Leishmania amazonensis | |
3alpha-p-coumaroyloxy-9beta-hydroxy-entkaur-16-en-19-oic acid | - |
Leishmania braziliensis | |
3alpha-p-coumaroyloxy-9beta-hydroxy-entkaur-16-en-19-oic acid | - |
Leishmania major | |
3alpha-p-coumaroyloxy-9beta-hydroxy-entkaur-16-en-19-oic acid | - |
Leishmania panamensis | |
3alpha-p-coumaroyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania amazonensis | |
3alpha-p-coumaroyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania braziliensis | |
3alpha-p-coumaroyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania major | |
3alpha-p-coumaroyloxy-ent-kaur-16-en-19-oic acid | - |
Leishmania panamensis | |
fischericin F | fischericin F is extracted from Ligularia fischeri. Fischericin F has ferulic acid as the main feature, bound to the ent-kaurane skeleton through an ester bond at C14 | Leishmania amazonensis | |
fischericin F | fischericin F is extracted from Ligularia fischeri. Fischericin F has ferulic acid as the main feature, bound to the ent-kaurane skeleton through an ester bond at C14 | Leishmania braziliensis | |
fischericin F | fischericin F is extracted from Ligularia fischeri. Fischericin F has ferulic acid as the main feature, bound to the ent-kaurane skeleton through an ester bond at C14 | Leishmania major | |
fischericin F | fischericin F is extracted from Ligularia fischeri. Fischericin F has ferulic acid as the main feature, bound to the ent-kaurane skeleton through an ester bond at C14 | Leishmania panamensis | |
methotrexate | - |
Leishmania amazonensis | |
methotrexate | - |
Leishmania braziliensis | |
methotrexate | - |
Leishmania major | |
methotrexate | - |
Leishmania panamensis | |
additional information | an in-house database of 360 kauranes (tetracyclic diterpenes) is generated, and a combined ligand- and structure-based virtual screening (VS) approach is performed to select potential inhibitors of Leishmania major (Lm) pteridine reductase I (PTR1). The best-ranked kauranes are employed to verify the validity of the VS approach through LmPTR1 enzyme inhibition assay, molecular dynamics and docking calculations and simulations. Inhibitor synthesis and structure-activity relationship, enzyme-inhibitor interaction analysis using LmPTR1 crystal structure (PDB ID 1E7W) in complex with its respective inhibitor, methotrexate (PDB ID MTX), overview | Leishmania amazonensis | |
additional information | an in-house database of 360 kauranes (tetracyclic diterpenes) is generated, and a combined ligand- and structure-based virtual screening (VS) approach is performed to select potential inhibitors of Leishmania major (Lm) pteridine reductase I (PTR1). The best-ranked kauranes are employed to verify the validity of the VS approach through LmPTR1 enzyme inhibition assay, molecular dynamics and docking calculations and simulations. Inhibitor synthesis and structure-activity relationship, enzyme-inhibitor interaction analysis using LmPTR1 crystal structure (PDB ID 1E7W) in complex with its respective inhibitor, methotrexate (PDB ID MTX), overview | Leishmania braziliensis | |
additional information | an in-house database of 360 kauranes (tetracyclic diterpenes) is generated, and a combined ligand- and structure-based virtual screening (VS) approach is performed to select potential inhibitors of Leishmania major (Lm) pteridine reductase I (PTR1). The best-ranked kauranes are employed to verify the validity of the VS approach through LmPTR1 enzyme inhibition assay, molecular dynamics and docking calculations and simulations. Inhibitor synthesis and structure-activity relationship, enzyme-inhibitor interaction analysis using LmPTR1 crystal structure (PDB ID 1E7W) in complex with its respective inhibitor, methotrexate (PDB ID MTX), overview | Leishmania major | |
additional information | an in-house database of 360 kauranes (tetracyclic diterpenes) is generated, and a combined ligand- and structure-based virtual screening (VS) approach is performed to select potential inhibitors of Leishmania major (Lm) pteridine reductase I (PTR1). The best-ranked kauranes are employed to verify the validity of the VS approach through LmPTR1 enzyme inhibition assay, molecular dynamics and docking calculations and simulations. Inhibitor synthesis and structure-activity relationship, enzyme-inhibitor interaction analysis using LmPTR1 crystal structure (PDB ID 1E7W) in complex with its respective inhibitor, methotrexate (PDB ID MTX), overview | Leishmania panamensis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
7,8-dihydrobiopterin + NADPH + H+ | Leishmania major | best substrate | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
7,8-dihydrobiopterin + NADPH + H+ | Leishmania amazonensis | best substrate | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
7,8-dihydrobiopterin + NADPH + H+ | Leishmania braziliensis | best substrate | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
7,8-dihydrobiopterin + NADPH + H+ | Leishmania panamensis | best substrate | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania amazonensis | O09352 | - |
- |
Leishmania braziliensis | A4HCP1 | - |
- |
Leishmania major | Q01782 | - |
- |
Leishmania panamensis | A0A088SA10 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
7,8-dihydrobiopterin + NADPH + H+ | best substrate | Leishmania major | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
7,8-dihydrobiopterin + NADPH + H+ | best substrate | Leishmania amazonensis | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
7,8-dihydrobiopterin + NADPH + H+ | best substrate | Leishmania braziliensis | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
7,8-dihydrobiopterin + NADPH + H+ | best substrate | Leishmania panamensis | 5,6,7,8-tetrahydrobiopterin + NADP+ | - |
? | |
additional information | 7,8-dihydro-L-biopterin and pyrimethamine (PMA) interact with enzyme residues S112, Y194, L226, and S227, molecular dynamics and docking study, overview | Leishmania major | ? | - |
- |
Synonyms | Comment | Organism |
---|---|---|
LaPTR1 | - |
Leishmania amazonensis |
LbPTR1 | - |
Leishmania braziliensis |
LmPTR1 | - |
Leishmania major |
LpPTR1 | - |
Leishmania panamensis |
pteridine reductase I | - |
Leishmania major |
pteridine reductase I | - |
Leishmania amazonensis |
pteridine reductase I | - |
Leishmania braziliensis |
pteridine reductase I | - |
Leishmania panamensis |
PTR1 | - |
Leishmania major |
PTR1 | - |
Leishmania amazonensis |
PTR1 | - |
Leishmania braziliensis |
PTR1 | - |
Leishmania panamensis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADPH | - |
Leishmania major | |
NADPH | - |
Leishmania amazonensis | |
NADPH | - |
Leishmania braziliensis | |
NADPH | - |
Leishmania panamensis |
General Information | Comment | Organism |
---|---|---|
additional information | hybrid models of LaPTR1 | Leishmania amazonensis |
additional information | hybrid models of LbPTR1 | Leishmania braziliensis |
additional information | hybrid models of LpPTR1 | Leishmania panamensis |